The two types of novel coronavirus antibody test reagents independently developed by Kisshealth's have entered the "White List" of China Chamber of Commerce for Import & Export of Medicines & Health Products. At the same time, we have also won access qualifications from a number of countries. As a methodology recommended by WHO, Serum total antibody method is suitable for rapid and automatic detection of large-scale population. Kisshealth contributes to China's efforts to continue supporting the international community in the fight against the epidemic.
In order to more effectively support the international community's joint response to the global public health crisis at this particular time when the global epidemic continues to spread, it is important to further strengthen the role of the international community in addressing the global public health crisis. Strengthening quality control of epidemic prevention materials and regulating export order. On April 25, 2020, the Ministry of Commerce, the General Administration of Customs, the National The General Administration of Market Supervision and Administration issued Announcement No. 12 of 2020 “Announcement on Further Strengthening the Quality Control of Export of Epidemic Prevention Materials” .
Kisshealth was selected on the "White List" by the China Chamber of Commerce for Import &Export of Medicines & Health Products
Since the outbreak of the novel coronavirus epidemic, Kisshealth has rapidly organized its research and development team to tackle the novel coronavirus and overcome all the difficulties to successfully complete the development of the novel coronavirus total antibody test.
Kisshealth's novel coronavirus test kit are suitable for testing not only in individual clinics, but also in large hospitals. Colloidal gold method issuitable for individual clinic, and immune turbidimetric method is suitable forlarge-scale population screening.
SARS-CoV-2 IgM/IgG AntibodiesTestKit（Latex particle-enhanced turbidimetric immunoassay）
The immunoturbidimetric test kit is an automatic methodology, which can be equipped with existing automatic equipment in hospitals, and can be applied to biochemical instruments of major brands in the world, such as Beckman, Roche, Abbott, etc., reducing the risk of healthcare workers being infected during testing, and can achieve thousands of simultaneous testing, which is suitable for large-scale screening and testing of novel coronavirus from large-scale third-class hospitals to primary care institutions. The test speed can reach 2000 tests per hour, reproducibility<3%, inter-batch variation <5%. It is suitable for a variety of complex application scenarios, such as isolation area for diagnosed patients, fever clinics in tertiary hospitals, primary hospitals, and community health clinics.
Advantages of novel coronavirus test kit (latex enhanced immune turbidimetry):
1. It has self-developed latex antigen coupling technology and liquid phase latex enhanced immunoturbidimetry In-vitro diagnosis technology;
2. The sample is blood, the source is flexible, reduce the risk of exposure and infection of medical staff, greatly relieve the pressure of clinical diagnosis and treatment;
3. It adopts the fastest liquid phase method, breaks through the restrictions on personnel places, shortens the detection time and is easy to operate ;
4. It can be widely used in medical institutions, and it is used in combination with the hospital automatic biochemical analyzer. For the majority of primary medical institutions, it has the advantages of light economic burden, controllable cost and strong compatibility;
5. It can be used for precise diagnosis in combination with nucleic acid detection and CT examination to realize rapid diagnosis of suspected patients and rapid screening of large-scale close contact population, so as to prevent the spread of the epidemic.
Severe Acute Respiratory Syndrome Coronavirus 2（SARS-CoV-2）IgM/IgG Test Kit（Immunochromatography）
Recently, there have been new confirmed cases in China for several consecutive days, which on the one hand reminds us to cherish the hard-won results of prevention and control, on the other hand, it also rings the alarm for us. According to real-time world statistics, as of 15:27 on June 17, Beijing time, the cumulative number of confirmed cases of COVID-19 worldwide exceeded 8.27million, of which 8181606 were overseas, and the cumulative number of deaths exceeded 441500, reaching 429758.
In the face of the international epidemic, Kisshealth assumes its due responsibility and social responsibility, bear in mind that it has the courage to take responsibility, always contribute its own strength to the fight against the epidemic. Kisshealth will build a health line of defense against the virus for the global anti-epidemic war. With actions, Kisshealth fulfills the solemn promise of building a community with a shared future for mankind.